ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

ABACHAI - Safety and efficacy of abatacept (s.c.) in patients with CTLA4 insufficiency or LRBA deficiency, a phase II clinical trial

Study limitation reported by the research below: “All enrolled patients were adults; generalisability to the paediatric population — where these conditions are commonly diagnosed — is uncertain.”

Papers